+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hemorrhagic Fever Drug"

Hemorrhagic Fever - Epidemiology Forecast - 2032 - Product Thumbnail Image

Hemorrhagic Fever - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline Review, H2 2020 - Product Thumbnail Image

Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 70 Pages
  • Global
From
Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline Review, H2 2020 - Product Thumbnail Image

Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 112 Pages
  • Global
From
Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H2 2020 - Product Thumbnail Image

Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 342 Pages
  • Global
From
Marburg Hemorrhagic Fever Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Marburg Hemorrhagic Fever Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • September 2023
  • 112 Pages
  • Global
From
Marburgvirus Infections (Marburg Hemorrhagic Fever) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Marburgvirus Infections (Marburg Hemorrhagic Fever) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 99 Pages
  • Global
From
Lassa Fever (Lassa Hemorrhagic Fever) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Lassa Fever (Lassa Hemorrhagic Fever) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 65 Pages
  • Global
From
Ebolavirus Infections (Ebola Hemorrhagic Fever) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Ebolavirus Infections (Ebola Hemorrhagic Fever) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 229 Pages
  • Global
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Hemorrhagic Fever Drugs are a class of drugs used to treat a variety of infectious diseases, including Ebola, Marburg, Lassa, and Yellow Fever. These drugs are used to reduce the severity of symptoms, reduce the risk of transmission, and improve the overall prognosis of the disease. They are typically administered intravenously or orally, and may be used in combination with other treatments. Common side effects of these drugs include nausea, vomiting, and diarrhea. The Hemorrhagic Fever Drug market is a rapidly growing sector of the Infectious Diseases Drugs market. This is due to the increasing prevalence of these diseases, as well as the need for effective treatments. As a result, many pharmaceutical companies have developed drugs to treat these diseases, and are actively researching new treatments. Some of the companies in the Hemorrhagic Fever Drug market include Gilead Sciences, Merck, Johnson & Johnson, GlaxoSmithKline, and Novartis. Show Less Read more